Changing Lives, One Cup at a Time
Currently Browsing: (Flex)

Protect Your Joints from AutoImmune Attack

More than 52 million Americans suffer from some form of arthritis.

Conventional medical wisdom has long held that rheumatoid arthritis results from an autoimmune attack on joints, while osteoarthritis was thought to result from age-related “wear-and-tear.”

For the first time, a team of researchers at Stanford University has demonstrated that this is not true!

It turns out that osteoarthritis is accompanied by the same pathological, pro-inflammatory immune factors involved in rheumatoid arthritis. Even more compelling was their finding that, if treatment is initiated before symptoms manifest, osteoarthritis may be entirely prevented.

Unfortunately, the list of available drugs to combat autoimmune disorders—including long-term treatment with corticosteroids like prednisone—is notoriously limited and comes with life-threatening complications, including obesity and diabetes.

The exciting news is a novel intervention has been identified that safely regulates the immune system to protect aging joint tissue from autoimmune attacks.

In this article, you will learn about natural collagen concentrate (NCC). Its unique molecular characteristics prevent immune cells’ overreaction to proteins normally found in cartilage and joint tissue that lead to pain and stiffness in both rheumatoid and osteoarthritis.

In multiple clinical trials using this proprietary collagen formulation, scientists at Harvard have been able to achieve relief of arthritic symptoms, with some patients experiencing complete remission!

You will also learn how NCC’s mode of action may be synergistically enhanced when combined with Boswellia serrata and two other joint-renewing nutrients.

The Stanford team’s discovery of the autoimmune link between osteoarthritis and rheumatoid arthritis was first presented in late 2011.

A group of 25 scientists concluded that the development of osteoarthritis is in great part driven by low-grade inflammatory processes. Specifically, the researchers discovered that the body launches an orchestrated, powerful attack on the synovial joints via signaling proteins normally used to fight infections. This autoimmune response, they reported, plays a key role in osteoarthritis onset.

Synovial joints are the most common joint types in the human body. They contain soft-tissue cushioning in addition to cartilage, along with synovial fluid, a natural lubricant. Knees, hips, and shoulders are just a few of the commonly arthritic joints that fall into this category.

What the Stanford team found was that low-grade inflammation is not merely an early symptom of osteoarthritic cartilage destruction in synovial joints—it is the trigger that causes it. The study also revealed that by targeting the autoimmune derangements that occur early on in the development of osteoarthritis, arthritis might be completely preventable.

They went on to point out that drugs intended to inhibit the arthritic reaction (like corticosteroids) paradoxically compromise the immune system. It would be far safer, they reported, if a natural way to turn off the body’s abnormal response were available.

Novel Method to Target the Pathologic Immune Response

Here’s how it works.These compelling new findings coincided with the development of a naturalintervention shown to protect tissues in aging joints called undenatured type II collagen.

Joints are lined with cartilage that both lubricates joints and absorbs physical impacts, preserving ease of motion and comfort. The bulk of the cartilage in your joints consists of collagen, a biomolecular protein critical to reducing friction and keeping joints youthful.

Osteoarthritis and rheumatoid arthritis both involve the structural degradation and gradual destruction of cartilage in aging joints. Osteoarthritis was long thought to be a consequence of simple “wear- and-tear” on joints (and hence largely inevitable). Rheumatoid arthritis, on the other hand, was recognized as an inflammatory autoimmune disease that arises when the body mistakenly attacks its own tissues, in this case the joint linings and cartilage.

We now know that both arise from pro-inflammatory immune factors.

Intrinsic to this process is the mobilization of “killer” T-cells into the joints by exposed collagen within the synovial lining.

Under normal conditions, collagen elicits no immune response. It is exposed collagen that immune cells mistakenly identify as invasive, foreign molecules.7 In response to the “threat,” inflammatory cytokines are released that draw in more “killer” T-cells.13 Those cells bombard exposed cartilage with toxic chemicals in order to destroy it, creating oxidative stress and further inflammation in the process.

Over time, these continuous biomolecular insults erode and disintegrate the cartilage that lubricates and functions as a shock-absorber in joints.

The resulting pain can become chronic and debilitating in lockstep with sensations of friction or grinding involved in joint movement. While less acute at rest, this pain is exacerbated by walking, standing, or any form of weight-bearing. Osteoarthritis sufferers often experience joint stiffness or immobility after periods of inactivity, for instance upon waking or after a long period of sitting.

NCC® Triggers Specific Oral Tolerance for Lasting Joint Relief

In both osteoarthritis and rheumatoid arthritis, the chief cause of autoimmune response is exposed collagen and the ensuing attack by sensitized killer T-cells.

Suppose an effective means of regulating killer T-cells before they encountered exposed collagen could be developed? This would “re-train” them to treat exposed collagen as a harmless substance and prevent joint degradation and destruction.

In 2000, the first hint of just such an intervention emerged.

A team of scientists at the University of Nebraska was surprised to find that chicken soup prevented the mobilization of immune system cells to sites of inflammation. Upon further analysis, it was not vegetables but a soluble component of the chicken broth itself that exerted this anti-inflammatory activity.

The researchers believe that it was likely the collagen from chicken bones in the broth that was the source of this beneficial anti-inflammatory effect.

New Way to Combat Rheumatoid and Arthritis

  • The most common joint disease, osteoarthritis, was long viewed as a disease of wear-and-tear. New findings reveal that it is one of a number of disorders caused by an abnormal response of the immune system.
  • Instead of the traditionally prescribed NSAIDs and immune suppressants, a revolutionary and side effect-free form of undenatured type II collagen called NCC® has been shown to desensitize the immune system and prevent pro-inflammatory autoimmune attacks on aging joints.
  • Undenatured type II chicken collagen has been shown in studies to be capable of activating the pathway known as induced oral tolerance, which teaches the immune system to correctly recognize exposed cartilage proteins as the body’s own tissues—instead of foreign microbes—thus preventing an inflammatory attack, a newly recognized cause of osteoarthritis.
  • The anti-inflammatory action of a novel composition of AKBA-enriched Boswellia serrata—and two joint-protective nutrients, glucosamine sulfate and boron, now available in highly bioactive formulations—can further boost the ability of undenatured type II chicken collagen to fight osteoarthritis, the painful condition behind so many visits to primary care physicians. Owing to its particular molecular structure, the chicken-derived type II collagen in UC-II® acts as a kind of “reverse vaccine,” one that regulates the immune system so that it stops mobilizing attacks against proteins normally found in healthy joint cartilage.

It does so by inducing what immunologists call specific oral tolerance—the desensitization of immune response to specific agents via an orally administered intervention. This is why NCC® may be likened to a kind of oral vaccine that reverses T-cell attacks on exposed cartilage.

Scientists at Harvard first studied the effects of NCC® on human patients with rheumatoid arthritis, long established as an autoimmune disorder. In a randomized, double-blind trial of 60 patients, undenatured type II chicken collagen produced a significant decrease in the number of swollen and painful joints within 3 months, compared to the placebo group. In fact, 14% of patients achieved complete remission. No side effects were found.

Later, a much larger study of 274 rheumatoid arthritis patients confirmed this finding, as did a study on patients with juvenile rheumatoid arthritis, a particularly aggressive form of this disease.

Turning their attention to osteoarthritis, scientists tested undenatured type II collagen on horses and dogs. They noted a reduction of 88% in measurable pain among horses given this formulation. In one study, moderately arthritic dogs given the undenatured collagen formulation were able to place more weight on sore limbs, and use them more naturally, relative to those given placebo, or those given chondroitin plus glucosamine.

The gold standard of scientific evidence is a randomized, double-blind, clinical study on humans. In a study of this type involving 52 adult human volunteers with osteoarthritis, who had an average age of 59, scientists found that in just 90 days, undenatured type II chicken collagen produced “significant enhancement in daily activities suggesting an improvement in their quality of life.”

In this trial, using the standardized WOMAC (Western Ontario McMaster Osteoarthritis Index) scale, scientists found that 40 mg a day of undenatured type II chicken collagen reduced osteoarthritis symptoms by 33% in 90 days. By comparison, the combination of 1,500 mg a day of glucosamine and 1,200 mg a day of chondroitin sulfate reduced WOMAC scores by only 14%.

Pain scores on the visual analog scale (VAS) decreased 40% for the collagen group, while pain scores for the glucosamine/chondroitin group decreased just 15%.

Finally, using the Lequesne’s functional index score—which measures pain during daily activities, such as walking—the study team found that undenatured type II collagen reduced this score by 20%, while the combination of glucosamine and chondroitin lowered the score by only 6%. All results were observed in just 90 days.

Why Undenatured Type II Collagen

As discussed earlier, immune system T-cells are tasked with recognizing and distinguishing between “self” molecules and “foreign” ones. They do this important work by responding to very specific molecular shapes and 3-dimensional structures. If T-cells in the blood are simply exposed, without any “training,” to a previously unrecognized protein structure (such as those found on joint collagen) they react violently and trigger a massive inflammatory response to destroy the protein.

This is why, when scientists want to create an animal model of arthritis, they inject collagen into their subjects, sensitizing the T-cells in their blood to the protein. Those circulating T-cells set up inflammation in the animal’s joints, with their rich supplies of collagen.

If T-cells are given adequate preparation, however, they can be “taught” that a specific molecule is a friend rather than a foe. Where does such T-cell “training” take place?

In the intestinal tract, specifically the lower end of the small intestine, which is rich in collections of immune tissue called Peyer’s patches. Peyer’s patches act as “training centers” for T-cells, exposing them to all sorts of molecular shapes that are natural components of the food we eat. In that fashion, we desensitize our immune systems and develop a natural tolerance to new foods without having constant allergic or inflammatory reactions.

So, by providing native collagen of the right 3-dimensional structure to the digestive tract, rather than to the bloodstream directly, we can “educate” our T-cells to ignore collagen when they encounter it in joints. Scientists say that this enables people to develop oral tolerance to collagen.

And oral tolerance to collagen powerfully suppresses joint inflammation, as has been shown in numerous laboratory studies. Oral administration of soluble type II collagen even prevents arthritis induced experimentally by collagen injections.

But not just any collagen works. Typical commercial processing causes collagen to become denatured, uncoiling from its normal helical shape and losing its 3-dimensional structure. Denatured collagen has no beneficial effects on joint inflammation.

A more natural form of collagen, called undenatured type II collagen, or UC-II®, has recently been developed. UC-II® is a highly effective product and a rich source of natural collagen. UC-II® retains its original 3-dimensional molecular structure, keeping it recognizable by T-cells in Peyer’s patches. And UC-II is robust enough to survive the harsh conditions in the stomach and small intestine, arriving at Peyer’s patches with its molecules intact.

Neutralizing the Pro-inflammatory 5-LOX Enzyme

Incorporating a safe anti-inflammatory agent in a joint protection program may provide an additional layer of defense against arthritic damage and pain, by helping to eliminate the immune trigger.

In traditional Indian medicine, the gum resin of Boswellia serrata is associated with alleviating inflammatory diseases such as arthritis. Double-blind, placebo-controlled studies have shown boswellia decreases swelling and pain in patients with osteoarthritis of the knee.

Various compounds within boswellia exert an anti-inflammatory action that is different from most anti-inflammatory agents: they inhibit the pro-inflammatory enzyme 5-lipoxygenase or 5-LOX.

A highly bioactive boswellia compound—called 3-O-acetyl-11-keto-b-boswellic acid, or AKBA—directly binds to and selectively inhibits 5-LOX.21,22 This prevents 5-LOX from facilitating the production of leukotriene, a pro-inflammatory compound that damages cartilage and joints. AKBA also reduces pro-inflammatory leukocyte elastase activity. The problem up to now has been limited bioavailability of AKBA following oral administration.

Fortunately, researchers have developed a boswellia formulation with enhanced bioavailability. Scientists administering this patented boswellia compound to animals found that it increased the bioavailability of AKBA in the systemic circulation by 52%, compared with a standard boswellia extract.

The researchers concluded that the AKBA-rich boswellia product “consistently…confers better anti-inflammatory efficacy,” and “provides more potential benefits in recovering articular cartilage damage… due to inflammatory insult in arthritis such as osteoarthritis or rheumatoid arthritis.”

In a double-blind, randomized, placebo-controlled study on human patients with osteoarthritis, 100 mg of the patented AKBA-enriched boswellia extract inhibited the cartilage-degrading enzyme MMP-3, and exhibited an anti-inflammatory action that was superior to a standard boswellia extract. Benefits were seen as early in the 90-day study as 7 days. The journal-published report described the formulation as a “novel synergistic composition.”


Flex has reunited this athlete with her first love, RUNNING!!

“One year ago, I hurt my knee doing an inflatable 5K, and since then, haven’t been able to run.

Doctors had put me on CQ10 to help the joints, but I saw no improvements and asked to be taken off it.

Just gave up on trying to run anymore, and just dealt with the nagging pain after high impact exercises.

Well, along came Marites and her different natural supplements from Javita.

She convinced me to try Flex, I did and just can’t believe the difference in my knees.

On Saturday did my first FOUR mile run in under an hour! No pain yesterday or today.” ~Rachel Hendricks

 


After 18 years of Hurting, I’m FINALLY Pain Free!!

“Back in 1998 I was diagnosed with Fibromyalgia. I also have scoliosis (3 curves in my spine), which has resulted in arthritis throughout my back. My hips are lopsided which adds to the pain. I’ve been in constant pain for over 18 years. My meds have included morphine with only minor pain relief.

I would know what the weather was before the weatherman. My friends use to joke that I was their personal barometer.

I started with Javita at the end of August. I was willing to try Flex. I’ve tried just about anything that came out that was SUPPOSE to reduce pain. (NOT).

After 2 months of drinking two flex everyday, I realized I wasn’t hurting. I was even sleeping at night.

Now I drink at least one a day unless I do a lot of activity.

I never thought I would ever be pain free without being unconscious.

And thanks to Burn & Control, I’ve lost 15 lbs.” ~Linda Hunt


ActiveBlendz Flex Product Call (Audio Recording)

Enjoy an EXCLUSIVE peak into the product development process, an overview of the causes of inflammation, the risks associated with long-term use of over-the-counter and prescription pain relievers, and discover the science, ingredients and studies supporting ActiveBlendz Flex. After listening, you’ll never go another day without this world-class, one-of-a-kind formula.


How Does ActiveBlendz Flex Compare to Aleve?

Check out how ActiveBlendz Flex compares to another popular national brand of over the counter pain relief Aleve.

Click here to download the comparison chart.


© 2018 Javita International Ltd. All rights reserved.  |  Visit Javita Corporate Website